Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,513.67
(
0.93%
)
US TECH 100
28,866.72
(
0.97%
)
Dow Jones
50,104.74
(
0.83%
)
Brent Oil
102.59
(
-1.06%
)
Bitcoin
81,508.36
(
2.80%
)
News Focus
News Focus
Post# of 257560
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122977
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: acgood post# 69467

Thursday, 12/04/2008 1:50:42 PM

Thursday, December 04, 2008 1:50:42 PM

Post# of 257560
>Couldn't this constitute another approved generic in the context of lowering MNTA’s royalty rate? Or would the sole approved generic designation apply to each of the specific product formulations?<

The latter. Technically, the Sandoz-MNTA Lovenox collaboration consists of two products: the vial and the syringe. Each of these has its own ANDA.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today